학술논문
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Document Type
Article
Author
Weiss, Aaron R ; Chen, Yen-Lin ; Scharschmidt, Thomas J ; Chi, Yueh-Yun; Tian, Jing; Black, Jennifer O; Davis, Jessica L; Fanburg-Smith, Julie C; Zambrano, Eduardo; Anderson, James; Arens, Robin; Binitie, Odion; Choy, Edwin; Davis, Justin W; Hayes-Jordan, Andrea; Kao, Simon C; Kayton, Mark L; Kessel, Sandy; Lim, Ruth; Meyer, William H; Million, Lynn; Okuno, Scott H; Ostrenga, Andrew; Parisi, Marguerite T; Pryma, Daniel A; Randall, R Lor; Rosen, Mark A; Schlapkohl, Mary; Shulkin, Barry L; Smith, Ethan A; Sorger, Joel I; Terezakis, Stephanie; Hawkins, Douglas S; Spunt, Sheri L; Wang, Dian
Source
In The Lancet Oncology August 2020 21(8):1110-1122
Subject
Language
ISSN
1470-2045